4 ms·
> Vaccine efficacy is against severe COVID illness, not against transmission. Since children have very little chance of a severe COVID infection, why the push
by naasking 5y ago
> Vaccine efficacy is against severe COVID illness, not against transmission.
Since children have very little chance of a severe COVID infection, why the push to vaccinate them then?
- yehosef 5y agolots of money?
- yehosef 5y agojust to put numbers on that - 28M children[1] * $20/dose [2] * 2 doses >= $1.1 B Considering you can't sue the vaccine manufactures for anything and the vaccines are being mandated in various venues, they are definitely a "safe and effective" way to make lots of money... [1] https://www.usnews.com/news/health-news/articles/2021-10-20/white-house-details-plans-to-vaccinate-28m-children-age-5-11 https://www.usnews.com/news/health-news/articles/2021-10-20/... [2] https://www.managedhealthcareexecutive.com/view/the-price-tags-on-the-covid-19-vaccines https://www.managedhealthcareexecutive.com/view/the-price-ta...
- gadyke 5y agoAs I understand it, precisely because they may then pass the infection on to those who may then end up with a severe illness (either because they're unvaccinated or because their protection is waning).
- deleted 5y ago[deleted]
- naasking 5y ago> As I understand it, precisely because they may then pass the infection on to those who may then end up with a severe illness But we've already established that the vaccine doesn't prevent transmission. It may slightly attenuate transmission, but nowhere near enough to stop the spread. Given these facts, the vaccine is mainly so the vulnerable populations can protect themselves, but most children aren't among those populations (obviously immunocompromised children are).
- horns4lyfe 5y agoIf the vaccine isn’t very effective in stopping transmission then how does the vaccine address this?
- gadyke 5y agoI don't think I've seen anyone suggest that there is absolutely no impact on transmission. Teenagers were previously a population in which the virus could freely circulate where now there's at least some limited curtailment. It wasn't my point, but others in this thread have also noted with sources that the level of impact on that younger population (and even small children), including long covid, also appears to be generally underestimated by the general population.
- astura 5y agoThis appears to be changing with Delta, which is causing unprecedented pediatric ICU admission. https://www.contagionlive.com/view/delta-variant-icauses-unprecedented-covid-19-disease-in-children https://www.contagionlive.com/view/delta-variant-icauses-unp...
- _Understated_ 5y agoThat article you linked (like literally every other one I've read) makes no mention of the numbers that recovered just fine. If they all made a recovery then this vaccine push is pointless.
- sschueller 5y agoChildren can still suffer under long COVID[1] and other complications that can occur with COVID. [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927578/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927578/
- ed25519FUUU 5y agoIs the chance of long covid higher than the chance of myocarditis? Is one more dangerous than the other? Myocarditis is very serious. Any child with it will need cardiology visits for most of their life.
- sschueller 5y agoCovid can also case myocarditis and at a higher rate[1] than after the vaccine. [1] https://www.newscientist.com/article/mg25133462-800-myocarditis-is-more-common-after-covid-19-infection-than-vaccination/ https://www.newscientist.com/article/mg25133462-800-myocardi...
- naasking 5y agoYes, but I thought we were talking about the push to vaccinate children, which is under say 14 years old. The younger you are, the less likely you are to have symptoms from COVID, so of the numbers listed in that article it's not clear what proportion of those complications from COVID came from the upper age brackets rather than the 12-15 year olds. And how stupid is it that these articles talk about studies but still don't actually link to them?
- pbak 5y ago> And how stupid is it that these articles talk about studies but still don't actually link to them? Well, the middle-man doesn't want you going to the source. What's his job gonna be if you do?
- naasking 5y agoSure, but now we're talking about the rate of complications from the vaccine vs. COVID among younger populations, and how deadly those complications are. Have you heard any of this nuanced debate, or have you just heard screaming to get everyone vaccinated with no nuance at all?
- ufo 5y agoWhile the risk of severe covid infection is lower in childred, it still exists and we would like to make it even smaller.
- rkk3 5y agoChildren's deaths are tragic but extremely low risk for covid. 558 children under 18 died have died in the US, out of a population of 73 Million. How low of risk do you need it to be?
- ufo 5y agoHere in Brazil we've had over 3500 deaths from people under 18, including over 320 babies under 1 year old. There have been cities where sick children were not able to get medical treatment because the pediatric ICU was over capacity. Most of these deaths could have been prevented if a vaccine were available.
- angelzen 5y agoAt the other end of the spectrum, in British Columbia (population 5 million), there have been 0 deaths in age group 10-19 and 2 deaths in age group <10. To further confound the issue, mortality rates in infants is significantly larger than in older kids, for US something like 500/100k vs 20/100k, reflecting a number of infants with congenital issues. Some of those end up counted as "death with covid", even if they were not going to make it either way. It is better to search for epi data for kids excluding 0-1 age group, if at all available. http://www.bccdc.ca/Health-Info-Site/Documents/Week_41_2021_BC_COVID-19_Situation_Report.pdf http://www.bccdc.ca/Health-Info-Site/Documents/Week_41_2021_...
- mdm_ 5y agoI've heard other people say this and in addition to the common response of helping to reduce spread, I wonder: won't those children grow up to become adults who might experience more serious infection/symptoms? Isn't this like the Chicken Pox vaccine that is commonly given to infants because the disease can be more severe when contracted as an adult?
- naasking 5y ago> I've heard other people say this and in addition to the common response of helping to reduce spread, I wonder: won't those children grow up to become adults who might experience more serious infection/symptoms? Children exposed to COVID develop strong immunity even if they have no symptoms [1], so the vaccine likely wouldn't convey any more protection than they've already developed. [1] https://pediatrics.duke.edu/news/children-mild-or-asymptomatic-covid-have-strong-antibodies https://pediatrics.duke.edu/news/children-mild-or-asymptomat...
- mdm_ 5y ago>Study authors said the findings suggest vaccinating young children against COVID-19 could also elicit a similar or greater degree of protection than that of adults. >Given similarities in the response to natural infection in children and adults, it is likely that vaccination against SARS-CoV-2 will also elicit a similar degree of protection across the full spectrum of age, as has recently been reported for the Pfizer-BioNTech vaccine in children 12–15 years of age (42). Though we cannot directly compare our results to the neutralizing antibody titers reported in vaccine trial studies, both the vaccine trial data and our results suggest that younger age may be associated with greater neutralizing antibody responses. I'm not a doctor, but doesn't this actually suggest that the younger the age we can administer COVID-19 vaccines, the stronger the antibody response is likely to be?
- hajile 5y agoThe vaccine develops a single antibody against a single spike protein. Natural immunity develops not only a spike protein antibody, but also antibodies against a bunch of other parts of the virus. If the virus alters the spike protein (eg, the A.30 variant which is pretty much immune to the vaccine), all those other antibodies against the unchanged parts are likely still effective at slowing the virus while new antibodies are developed.